Sandy Spring Bank’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
$21.1M Buy
25,550
+4,546
+22% +$3.78M 0.89% 25
2024
Q4
$16.2M Buy
21,004
+1,853
+10% +$1.53M 0.66% 30
2024
Q3
$17M Buy
19,151
+1,473
+8% +$1.32M 0.7% 31
2024
Q2
$16M Buy
17,678
+1,546
+10% +$1.24M 0.71% 29
2024
Q1
$12.6M Buy
16,132
+296
+2% +$211K 0.57% 36
2023
Q4
$9.23M Buy
15,836
+905
+6% +$528K 0.46% 51
2023
Q3
$8.02M Buy
14,931
+1,908
+15% +$983K 0.45% 54
2023
Q2
$6.11M Buy
13,023
+613
+5% +$257K 0.33% 73
2023
Q1
$4.26M Buy
12,410
+2,718
+28% +$917K 0.24% 96
2022
Q4
$3.55M Buy
9,692
+2,407
+33% +$853K 0.21% 113
2022
Q3
$2.35M Buy
7,285
+1,553
+27% +$492K 0.15% 134
2022
Q2
$1.86M Sell
5,732
-394
-6% -$118K 0.11% 158
2022
Q1
$1.75M Buy
6,126
+1,396
+30% +$359K 0.09% 173
2021
Q4
$1.31M Sell
4,730
-151
-3% -$38.3K 0.06% 194
2021
Q3
$1.13M Buy
4,881
+1,250
+34% +$309K 0.06% 199
2021
Q2
$834K Sell
3,631
-145
-4% -$29.1K 0.04% 219
2021
Q1
$705K Sell
3,776
-88
-2% -$17.2K 0.04% 223
2020
Q4
$652K Buy
3,864
+972
+34% +$145K 0.04% 222
2020
Q3
$428K Sell
2,892
-21
-0.7% -$3.25K 0.03% 240
2020
Q2
$478K Buy
2,913
+1,216
+72% +$187K 0.04% 232
2020
Q1
$235K Sell
1,697
-162
-9% -$22.3K 0.02% 267
2019
Q4
$245K Buy
1,859
+94
+5% +$10.9K 0.02% 281
2019
Q3
$197K Buy
1,765
+665
+60% +$74K 0.02% 299
2019
Q2
$122K Hold
1,100
0.01% 343
2019
Q1
$142K Sell
1,100
-165
-13% -$20.1K 0.01% 320
2018
Q4
$146K Hold
1,265
0.01% 311
2018
Q3
$136K Sell
1,265
-257
-17% -$25.7K 0.01% 332
2018
Q2
$130K Sell
1,522
-100
-6% -$8.21K 0.01% 344
2018
Q1
$125K Sell
1,622
-354
-18% -$28.5K 0.01% 348
2017
Q4
$167K Sell
1,976
-608
-24% -$51.7K 0.02% 300
2017
Q3
$221K Buy
2,584
+47
+2% +$3.85K 0.02% 277
2017
Q2
$209K Buy
2,537
+339
+15% +$27.7K 0.02% 290
2017
Q1
$185K Buy
2,198
+750
+52% +$60.1K 0.02% 291
2016
Q4
$107K Sell
1,448
-1,195
-45% -$89K 0.01% 344
2016
Q3
$212K Buy
2,643
+1,100
+71% +$88K 0.02% 282
2016
Q2
$122K Hold
1,543
0.01% 333
2016
Q1
$111K Sell
1,543
-236
-13% -$17.9K 0.01% 342
2015
Q4
$150K Buy
1,779
+35
+2% +$2.9K 0.02% 300
2015
Q3
$146K Sell
1,744
-408
-19% -$34.4K 0.02% 302
2015
Q2
$179K Buy
2,152
+111
+5% +$8.46K 0.02% 304
2015
Q1
$148K Buy
2,041
+13
+0.6% +$926 0.02% 312
2014
Q4
$140K Buy
2,028
+275
+16% +$18.6K 0.02% 296
2014
Q3
$114K Buy
1,753
+1,000
+133% +$63.3K 0.01% 319
2014
Q2
$47K Hold
753
0.01% 424
2014
Q1
$44K Buy
753
+500
+198% +$27.9K 0.01% 390
2013
Q4
$13K Sell
253
-75
-23% -$3.76K ﹤0.01% 534
2013
Q3
$17K Sell
328
-75
-19% -$3.93K ﹤0.01% 492
2013
Q2
$19K Buy
+403
New +$21.9K ﹤0.01% 454

Other funds holding LLY

Sandy Spring Bank's LLY Position: Q1 2025 in Review

Sandy Spring Bank increased its Eli Lilly (LLY) stake by 22% in Q1 2025, buying an estimated $3.78M and bringing the position to 25,550 shares worth $21.1M. The position accounts for 0.89% of the portfolio, ranked #25.

Sandy Spring Bank first reported a position in LLY in Q2 2013 and has held it in 48 quarters since. 3,920 funds tracked by Wall St. Rank hold LLY as of Q1 2025.

  • Sandy Spring Bank held 25,550 shares of Eli Lilly worth $21.1M as of Q1 2025.
  • Sandy Spring Bank bought 4,546 Eli Lilly shares in Q1 2025, an estimated $3.78M.
  • Eli Lilly made up 0.89% of Sandy Spring Bank's portfolio in Q1 2025, its #25 holding.
  • Sandy Spring Bank first reported a position in Eli Lilly in Q2 2013 and has held it in 48 quarters since.
  • 3,920 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2025.

Based on Sandy Spring Bank's 13F filing for Q1 2025, filed 12 May 2025.